Our growth plans are well underway and we wish to achieve financial flexibility and strength to deliver on our strategic objectives. We are excited about the Group’s initiatives and I look forward to reporting on further progress.
Stevia Biotech wish to be pioneering the extraction of high quality natural sweeteners from stevia for the food and beverage industry. We wish to be market leader in the production and sale of high purity Rebaudioside-A (Reb-A for short), a high intensity sweetener extracted from the Stevia rebaudiana Bertoni plant (stevia).
Stevia Biotech is the first company to produce Reb-A on a commercial scale. As well as being all natural, Reb-A provides consumers with various healthy benefits including having no caloric content and a low glycemic index, making it suitable for consumption by diabetics.
It also has a taste profile which is a credible, natural and healthy alternative to sugar and artificial sweeteners. Reb-A therefore enables our blue chip customers to develop new products in response to consumer demand for healthy beverages, as evidenced by the falling sales of fizzy drinks and increased consumption of bottled water and juices.
The Group’s product portfolio also includes Stevia and steviol glycosides, bulk zero calorie sugar substitute used by food and beverage manufacturers and SteviaLife, a table top sweetener.